These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6752325)

  • 1. Inter-species comparison of somatomedin structure using immunological probes.
    Wilson DM; Hintz RL
    J Endocrinol; 1982 Oct; 95(1):59-64. PubMed ID: 6752325
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth and somatomedins.
    Hall K; Sara VR
    Vitam Horm; 1983; 40():175-233. PubMed ID: 6324479
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence from radioligand assays that somatomedin-C and insulin-like growth factor-I are similar to each other and different from other somatomedins.
    Van Wyk JJ; Svoboda ME; Underwood LE
    J Clin Endocrinol Metab; 1980 Jan; 50(1):206-8. PubMed ID: 7350184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatomedin-C shares the carboxy-terminal antigenic determinants with insulin-like growth factor-I.
    Hintz RL; Rinderknecht E
    J Clin Endocrinol Metab; 1980 Sep; 51(3):672-3. PubMed ID: 6157699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor I/somatomedin C (IGF-I/Sm C): comparison of natural, solid phase synthetic and recombinant DNA analog peptides in two radioligand assays.
    Schalch D; Reismann D; Emler C; Humbel R; Li CH; Peters M; Lau E
    Endocrinology; 1984 Dec; 115(6):2490-2. PubMed ID: 6389098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sensitive radioimmunoassay for somatomedin-C/insulin-like growth-factor I based on synthetic insulin-like growth factor 57-70.
    Hintz RL; Liu F; Chang D; Seegan G
    Horm Metab Res; 1988 Jun; 20(6):344-7. PubMed ID: 3417219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic insulin-like growth factor II.
    Li CH; Yamashiro D; Hammonds RG; Westphal M
    Biochem Biophys Res Commun; 1985 Mar; 127(2):420-4. PubMed ID: 3884009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Somatomedin].
    Takano K
    Horumon To Rinsho; 1977 Feb; 25(2):153-8. PubMed ID: 404103
    [No Abstract]   [Full Text] [Related]  

  • 9. Pitfalls in the somatomedin-C radioimmunoassay.
    Furlanetto RW
    J Clin Endocrinol Metab; 1982 May; 54(5):1084-6. PubMed ID: 7199537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum.
    Daughaday WH; Mariz IK; Blethen SL
    J Clin Endocrinol Metab; 1980 Oct; 51(4):781-8. PubMed ID: 6998997
    [No Abstract]   [Full Text] [Related]  

  • 11. [Somatomedins. Structure, physiology and clinical data].
    Van den Brande JL
    Ann Endocrinol (Paris); 1986; 47(5):350-62. PubMed ID: 2435221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels.
    Tamborlane WV; Hintz RL; Bergman M; Genel M; Felig P; Sherwin RS
    N Engl J Med; 1981 Aug; 305(6):303-7. PubMed ID: 7017416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dwarfism associated with normal serum growth hormone and increased bioassayable, receptorassayable, and immunoassayable somatomedin.
    Lanes R; Plotnick LP; Spencer EM; Daughaday WH; Kowarski AA
    J Clin Endocrinol Metab; 1980 Mar; 50(3):485-8. PubMed ID: 6987254
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo and in vitro effect of liver on somatomedin generation.
    Minuto F; Barreca A; Del Monte P; Buffa C; Bevevino R; Montale F; Torre G; Giordano G
    Horm Metab Res; 1984 Dec; 16(12):663-6. PubMed ID: 6098543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatomedin-C is not increased in the serum of patients with amyotrophic lateral sclerosis.
    Denys EH; Pelle-Day G; Spencer EM
    Muscle Nerve; 1988 Sep; 11(9):1000-1. PubMed ID: 3173414
    [No Abstract]   [Full Text] [Related]  

  • 16. Purification of somatomedin-C from human plasma: chemical and biological properties, partial sequence analysis, and relationship to other somatomedins.
    Svoboda ME; Van Wyk JJ; Klapper DG; Fellows RE; Grissom FE; Schlueter RJ
    Biochemistry; 1980 Feb; 19(4):790-7. PubMed ID: 7188854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum somatomedin binding proteins: physiologic significance and interference in radioligand assay.
    Daughaday WH; Kapadia M; Mariz I
    J Lab Clin Med; 1987 Mar; 109(3):355-63. PubMed ID: 2434590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between growth hormone and somatomedin.
    Van Wyk JJ; Underwood LE
    Annu Rev Med; 1975; 26():427-41. PubMed ID: 167653
    [No Abstract]   [Full Text] [Related]  

  • 19. Measurement of somatomedin-related peptides in fetal, neonatal, and maternal rat serum by insulin-like growth factor (IGF) I radioimmunoassay, IGF-II radioreceptor assay (RRA), and multiplication-stimulating activity RRA after acid-ethanol extraction.
    Daughaday WH; Parker KA; Borowsky S; Trivedi B; Kapadia M
    Endocrinology; 1982 Feb; 110(2):575-81. PubMed ID: 7035142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the synthesis of a somatomedin similar to insulin-like growth factor I by chick embryo liver cells.
    Haselbacher GK; Andres RY; Humbel RE
    Eur J Biochem; 1980 Oct; 111(1):245-50. PubMed ID: 7002559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.